What is GIBEX ?

The Global Institute for BioExploration (GIBEX) is a global research and development network that promotes ethical, natural product-based pharmacological bioexploration to benefit human health and the environment in developing countries. GIBEX was established by Rutgers, the State University of New Jersey, and the University of Illinois at Urbana-Champaign. Both are leading US universities with strong records of building successful international programs in discovering and developing life-saving medicines.

Alaska Natives Explore the Health Benefits of Indigenous Berries Using “Screens to Nature” More...

The Opportunity

Worldwide slow-down of the synthetic chemistry-based pharmaceutical industry provides opportunities for novel, effective, and scientifically developed natural medicines from the diverse and relatively unexplored flora and fauna of our planet. GIBEX translates these opportunities into improved human health, environment conservation as well as increased economic and educational activities in developing countries.

Guggulipid: ancient medicine for new therapeutic targets   Gum resin from the tree Commiphora mukul Engl. is one of the most popular therapeutic agents in Ayurveda, the traditional Indian system of practicing medicine.More...

About us & Partners

Drug Discovery Paradigm     Reversing the Flow' Concept         Diseases Targeted by STN   Sustainability Pledge    General Targets     Scientific Targets   Economic Targets    Member Countries

Programs

Central Asia ICBG  GIBEX Africa   Bioexploration in Tanzania   GIBEX-Americas

Dr. David Gammon at Rutgers University

GIBEX-Rutgers hosted Dr. David Gammon, Associate Professor of Organic Chemistry and Senior Associate of GIBEX-Africa at the University of Cape Town (UCT), South Africa, April 27-29, 2007 at Rutgers, The State University of New Jersey, New Brunswick, New Jersey.More...